Treatment Success in Mild Psoriasis Patients With Fixed-Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam: Results From the PSO-FAST Trial

Main Article Content

Karen Veverka
Jes Hansen
Maria Yaloumis
Leon Kircik
Linda Stein Gold

Keywords

Psoriasis, Topical, Calcipotriene, Betamethasone, Efficacy

Abstract

Abstract not available.

References

1. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad
Dermatol. 2009;58(5):826-850.

2. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management and treatment of psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2009;60:643-659.

3. Leonardi C, Bagel J, Yamauchi P, et al. Efficacy and safety of calcipotriene plus betamethasone dipropionate aerosol foam in
patients with psoriasis vulgaris – a randomized phase III study (PSO-FAST). J Drugs Dermatol. 2015;14(2):1468-1477.

4. Enstilar (calcipotriene and betamethasone dipropionate) foam Prescribing Information, Madison, NJ: LEO Pharma, In

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>